Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic Reactions
Well-characterized and manageable...
Well-characterized and manageable...
Hematologic reactions are expected and manageable 1 ...
In many healthcare systems, healthcare professionals are the primary source of direct care for patients. At Novartis, we are committed to support the consultation process between patients and healthcare professionals.
You may...